During the 24 hr incubation period, the A␤ peptide alone became aggregated to a lesser extent (2-fold less) than the A␤ peptide plus purified brain G4 AChE (240 M A␤ with AChE at 2.4 M) ( Figure 1A) . To quantitate the level of peptide aggregation further, we measured the amount of remaining soluble peptide after incubation by a sedimentation assay. A␤ peptide aggregated only partially in the absence of AChE (26%); however, addition of AChE at 100:1 molar ratio increased the aggregate material up to 80%. To quantitate partially the amount of amyloid formed under each condition, we used a novel method based on the fluorescence emission by thioflavine-T bound to amyloid (Naiki et al., 1991; LeVine, 1993) . Thioflavine-T binds specifically to amyloid, and this binding produces a shift in the emission spectra and a fluorescence enhancement that is directly proportional to the amount of amyloid formed (LeVine, 1993) . Freshly suspended A␤1-40 either alone or coincubated with AChE in the fluorescence buffer showed no specific thioflavine-T emission at 485 nm. During the incubation period, there was a gradual increase of the fluorescence in both 240 M A␤ 1-40 alone, and in A␤ coincubated with 2.4 M AChE up to 24 hr ( Figure 1B) . However, the rate of increase was greater for A␤ coincubated with AChE. In fact, A␤1-40 coincubated with AChE displayed fluorescence values that were 2.8-fold higher than for A␤ alone. AChE alone (2-10 M) showed no increase in fluorescence over this time period. A␤ 1-40 incubated with bovine serum albumin, ubiquitin, collagen type IV, or fibronectin gave similar fluorescence values to A␤ alone (data not shown). The next step was to study the effect of AChE concentration upon amyloid formation. After 24 hr, an increase in the fluorescence emission was observed with increasing AChE concentrations up to 2.4 M. At 1.2 M (1:200 molar ratio, AChE:A␤ 1-40 peptide), 60% of the maximal increase was seen ( Figure 1C ). These results are consistent with a faster aggregation of the A␤ in the presence of AChE.
Characterization of the Amyloid Fibrils Induced by AChE
The morphology of the amyloid fibrils produced in the presence of affinity purified G 4 AChE form was examined by electron microscopy after 5 days of incubation at room temperature. Negatively stained A␤1-40 assembled at (pH 7.4) revealed that the fibrous aggregates are com- Experimental conditions were those described in Figure 1 . In both Aliquots of both preparations, A␤1-40 (A), A␤1-40 plus AChE (B) and the turbidity measurement (A) and in the fluorescence studies (B), AChE alone (C) were adsorbed onto 300-mesh Formvar-coated grids the time of incubation was 24 hr. Different peptides (A␤ 1-40 , A␤ Valand negative-stained with 2% uranyl acetate. The specimens were 18→Ala and A␤G ␣lu-22→Gln ) alone (1 mg/ml in 0. the Dutch Variant A␤ Glu-22→Gln , to Form Amyloid To better understand the effect of AChE on amyloid formation, A␤ analogs containing single amino acid sub-(9-fold) was observed after 24 hr of incubation ( Figure  3B ). These results indicate that AChE produces a greater stitutions were used. First, we studied the single mutation of Val-18→Ala that induces a significant increment effect on those peptides that have less ␤-sheet structure. of ␣-helical structure and dramatically diminishes fibrillogenesis (Soto et al., 1995) . When the A␤Val-18→Ala was
The Dutch variant A␤Glu-22→Gln is found in hereditary cerebral hemorrhage with amyloidosis, Dutch type (Levy incubated at a concentration of 240 M, only a small increase in turbidity was observed after 24 hr of incubaet al., 1990 ). This variant is highly amyloidogenic in vitro, forming more stable fibrils more rapidly than wild-type tion. However, coincubation with purified brain AChE (2.4 M) resulted in a 5-fold increase in turbidity (Figure A␤ 1-40 (Wisniewski et al., 1991) . To test the effect of AChE on the aggregation of the Dutch variant, the peptide was 3A). When the amyloid formation was measured by thioflavine-T fluorescence, a clear increase in fluorescence incubated at 240 M with AChE at 2.4 M. Both turbidity Binding of different peptides with AChE was studied by size exclusion chromatography (Barrow et al., 1992) . 10 g of each peptide (wild-type A␤ 1-40 and the variants A␤ Val 18→Ala [A] and A␤ [Q]) with AChE (molar ratio of A␤:AChE, 15:1) for one hr at room temperature in a final volume of 40 l. After incubation, the samples were loaded in Sephadex G-25 columns preequilibrated in 0.1 M Tris-HCl, (pH 7.4), and eluted by a brief spin. Eluted samples were analyzed by SDS-polyacrylamide gels, using the Tris-Tricine system (Schagger and van Jagow, 1987 Figures 3A and 3B ). These results indicate that tetrameric AChE had little effect on the To make sure that the effect of AChE on amyloid formation was not the result of an A␤ aggregation-promoting self-aggregation of the highly amyloidogenic Dutch variant. No differences were detected in the morphology contaminant that copurified with the bovine brain G4 form, amyloid formation was studied in the presence of (electron microscopy) of the amyloid fibrils formed by the mutant A␤ , or the Dutch variant plus AChE both human and mouse recombinant AChE. The recombinant enzymes were purified by affinity chromatogracompared with the wild-type A␤ 1-40 (data not shown). Previously we have shown that A␤ peptide binds AChE phy from the medium of transfected HEK-293 cells (Velan et al., 1991; Bourne et al., 1995) . Mouse AChE (Inestrosa et al., 1994, LatinoAmerican Congress of Pharmacology, abstract; Alvarez et al., 1995) . Therefore, we tested the ability of the two A␤ analog (A␤ Val-18→Ala and AChE exhibits considerable structural polymorphism was affinity purified from bovine caudate nucleus on an acridineSepharose column, as described previously (Inestrosa et al., 1987) . (Inestrosa and Perelman, 1989; Massoulié et al., 1993) ;
The hydrophilic G4 AChE was prepared from the hydrophobic G4 therefore, we studied the ability of several molecular after proteolytic digestion using proteinase K, and the monomeric forms of AChE to promote the assembly of A␤1-40 into hydrophilic AChE form was prepared from the hydrophobic G4 form amyloid fibrils and to bind the A␤ peptide. As shown in by mild proteolytic digestion with trypsin (Fuentes et al., 1988) . In Table 1 , hydrophobic and hydrophilic tetrameric (G 4 ) both cases, the hydrophilic G 4 and the monomeric forms of AChE thioflavine-T fluorescence. In both cases, the effect is appproximately 75% of that observed with the affinitypurified bovine brain G 4 tetramer. These results indicate that AChEs from different sources are able to accelerate the aggregation of A␤ 1-40 into amyloid fibrils, making unlikely that an aggregation-promoting factor other than AChE could be responsible for the results presented in this paper.
Propidium, a Peripheral Anionic Site Ligand, Affects the Formation of Amyloid Induced by AChE
Besides active site inhibitors, AChE activity is also inhibited by peripheral anionic site ligands (Radic et al., 1991; Eichler et al., 1994) . When the effect of AChE on amyloid formation was studied in the presence of propidium, an exclusive peripheral anionic site ligand (Taylor and Lappi, 1975) , this compound inhibited almost 75% of the enhancement of amyloid formation triggered by AChE ( Figure 6A ). Bisquaternary ligands are well-known inhibitors of AChE (Bergmann et al., 1950; Bergmann and Segal, 1954) and their inhibitory capacity has been ascribed to their ability to span the distance between the active center and the peripheral anionic site (Main, 1976) . When the effect of AChE on amyloid formation was studied in the presence of the nonselective bisquaternary inhibitor decamethonium, this compound inhibited nearly 80% of the enhancement of amyloid fibril formation ( Figure 6A ). However, BW 284C51, a selective bisquaternary inhibitor, did not inhibit amyloid formation at 2 M. On the other hand, when the cationic active center ligand edrophonium (Wilson and Quan, 1958; Silman et al., 1994) was included, no effect on amyloid formation was observed ( Figure 6A ). These results suggest that the catalytic active center of AChE does not participate in the interaction of the enzyme with the A␤ peptide, whereas it is possible that the peripheral anionic binding site of AChE may be involved in amyloid formation. and it has been detected in senile plaques and also in and the AChE activity was determined by the Ellman method (Ellman neurofibrillary tangles (Mesulam et al., 1987; Gó mezet al., 1961) . (B) Amyloid formation by AChE from several sources. Purified G 4 hr ( Figure 6B ). The same results were obtained when the relative concentration of BuChE in relation to A␤ was increased in the incubation sample (2.4 M BuChE with 120 and 60 M A␤1-40). Because BuChE lacks Tyr-72, (mAChE) sediments as a 4.8 S monomeric G1 form and human AChE (HuAChE) sediments as two molecular Tyr-124 and Trp-286, residues that form the peripheral anionic binding site of AChE (Harel et al., 1992 ; Radic forms of 6.5 S and 10.7 S, which correspond to G 2 and G 4 species ( Figure 5A ). Both mAChE and HuAChE were Barak et al., 1994) , it is possible that the absence of such amino acids may be involved in the assayed for their capacity to accelerate amyloid formation. As Figure 5B indicates, coincubation of A␤ with lack of effect of BuChE on the formation of amyloid fibrils. either mAChE or HuAChE resulted in a clear increase in 
Discussion

AChE Is an Amyloid-Promoting Factor
In the present study, the ability of purified AChE to promote the assembly of A␤ 1-40 peptide into amyloid filaments was demonstrated. AChE induced a higher increase in the amount of amyloid formed on a poorly amyloidogenic A␤ analog created by substituting alanine for valine at position 18. Conversely, AChE was not able to increase the formation of amyloid by the Dutch variant of A␤, in which a Glu-22→Gln substitution generates a higher amyloidogenic variant (Wisniewski et al., 1991; Soto et al., 1995) . These results are in agreement with our recent findings that AChE modulates amyloid formation by inducing a conformational change in A␤ (Alvarez et al., 1995) . Alternatively, AChE could act as a heterogeneous nucleator, increasing the rate of fibrillo- An additional possibility is that AChE could bind to and (A) Amyloid formation was quantified through the thioflavine-T assay stabilize the growing amyloid fibrils. (Naiki et al., 1989; LeVine, 1993) . Aliquots of A␤ Val-18→Ala in a concentration of 1 mg/ml (0.25 M) were incubated, with or without 2.4 M AChE in the presence of 50 M propidium, 100 M decamethonium,
AChE from Different Sources and Quaternary
2 M BW284C51, and 100 M edrophonium for 24 hr in 0.1 M
Structure Promotes Amyloid Formation
Tris-HCl (pH 7.5), at room temperature. Then, amyloid formation Human, bovine, and mouse AChE were able to accelerwas quantified by thioflavine-T fluorescence.
ate the aggregation of A␤ 1-40 into amyloid fibrils. These ings, and therefore, if one desires to make any suggestion about the effect of AChE on AD pathology, it is mandatory to demonstrate that HuAChE is able to proAChE Is a Potent Amyloid-Promoting Factor We examined the relative ability of purified brain G4 mote amyloid formation. Also, recent studies have shown that the transgenic expression of HuAChE inAChE, recombinant apolipoprotein E3 (apoE3), and ␣1-antichymotrypsin (␣1-ACT) to promote amyloid formaduces progressive memory deterioration in mice (Beeri et al., 1995) , a fact that may be related to the effect tion. As shown in Table 2 , a small effect was observed with apoE3. This result is consistent with recent studies described in this paper, particularly considering that G1 or A12 AChE forms may be involved. From a biological showing that recombinant apoE is not an efficient promoter of A␤ fibrillogenesis (Castano et al., 1995;  Evans point of view, it is interesting that two different recombinant enzymes (HuAChE and mAChE) were able to accelet al., 1995). Unexpectedly, ␣ 1 -ACT showed only a relatively weak capacity to form amyloid (Ma et al., 1994) .
erate amyloid formation, because it would be relatively easy to employ site-directed mutagenesis and molecuWe conclude that AChE is an effective promoting factor of amyloid formation. lar modeling techniques to examine different mutants of AChE for their capacity to bind A␤ and to promote with this possibility. Barak et al. (1994) proposed that amyloid formation.
the peripheral anionic site of HuAChE consists of a numThe quaternary structure adopted by AChE did not ber of binding sites close to the entrance of the active affect the capacity of the enzyme to accelerate the amysite gorge. Their data suggest that propidium, decaloid formation; in fact, tetrameric (both hydrophobic and methonium, and BW284C51 bind to the peripheral site hydrophilic), as well as dimers and monomers of the in a distinctive manner and that the nature and extent enzyme, were able to accomplish such a function. This of participation of the individual residues is ligand deis important because changes in the distribution of the pendent. This functional degeneracy is in part the result AChE molecular forms occur during AD (Younkin et al., of the ability of the Trp-286 indole moiety to interact 1986; Nakamura et al., 1990; Arendt et al., 1992), includeither via stacking (with propidium), via p-cation attracing the appearance of an anomalous molecular form of tions (with decamethonium), or aromatic-aromatic interthis enzyme (Navaratnam et al., 1991) .
actions (with BW284c51). Another view is provided by the recent analysis of the crystal complex of AChE and fasciculin, a 61 amino acid peptide isolated from mamba The Catalytic Active Center of AChE Is Not venoms (Bourne et al., 1995; Harel et al., 1995) . This Required for Amyloid Formation toxin binds to the residues belonging to the peripheral Some features of AChE suggest that the enzyme may anionic site of AChE, although other residues like Pro-78 have a potential noncatalytic function(s) other than aceand Gly-342 in mAChE also contribute to the fasciculin tylcholine hydrolysis (Layer et al., 1993; binding site. Whether they should also be considered 1993). Our results, showing that the ability of AChE to as part of the peripheral anionic site is not certain promote amyloid fibril formation was not affected by a (Bourne et al., 1995; Harel et al., 1995) . In this context, specific active center inhibitor, indicate that the enzyme we recently found that 1 nM fasciculin inhibits only 30% was able to perform such function by using a structural of the enhancement of amyloid formation triggered by domain other than the active center. This result suggests the bovine brain G 4 AChE (C. A. P., F. Dajas., N. C. that the aggregation of the A␤ peptide promoted by I., unpublished data). Therefore, it is possible that the AChE is independent of its well-known catalytic activity.
interaction of the A␤ peptide with the peripheral anionic binding site(s) of AChE may be more complex than we A Hydrophobic Environment Close would expect, by simply following the well-established to the Peripheral Anionic Binding specificity of the enzyme. Of course, further studies are Site(s) of AChE Is Probably Involved necessary to identify the structural AChE domain inin the Formation of Amyloid volved in the interaction with the A␤ peptide. For the In 1950, on the basis of binding studies of bisquaternary time being, we would like to propose the following as compounds to AChE, Nachmansohn and coworkers a working hypothesis: the domain of AChE involved in proposed the existence of a second anionic site on the the acceleration of amyloid formation is related to a enzyme, which became known as the peripheral anionic hydrophobic environment close to the peripheral anionic site (Bergmann et al., 1950) . Later, Changeux (1966) binding site(s) of the catalytic subunit of the enzyme. showed that the action of reversible inhibitors of AChE could not be explained simply on the basis of a single site, but rather that certain ligands affect catalysis Role of Other Senile Plaque-Associated through binding to an allosteric site. The ligand propidProteins in Amyloid Formation ium binds to AChE and is selective for the peripheral Amyloid plaque is an ordered, fibrous protein aggregate site (Taylor and Lappi, 1975) . The peripheral site of AChE characteristic of AD brain (Lansbury, 1992 ; Soto et al., appears to be located at or close to the enzyme surface, 1994). It has been suggested that endogenous factors near the entrance of the active site gorge (Weise et al., that accelerate amyloid deposition could play a signifi-1990; Amitai and Taylor, 1991; Sussman et al., 1991;  cant role in the pathogenesis of AD (Jarrett and LansSussman and Silman, 1992; Silman et al., 1994), and bury, 1993) . Although the present investigation has deperipheral site ligands might act by partially obstructing termined that AChE is an A␤-associated component that the entrance to the gorge (Taylor and Radic, 1994) .
promotes amyloid fibril formation, it is possible that Within this context, it is possible that the presence of a other A␤-associated proteins may be involved. These peripheral site blocker will not permit the A␤ peptide to include amyloid-P component (Kalaria et al., 1991) , apo interact with AChE, determining a lack of effect of the E (Wisniewski and Frangione, 1992), apo J (Ghiso et esterase over the amyloid fibril formation process. Conal., 1993) , ␣ 1 -ACT (Ma et al., 1994) , extracellular matrix sistent with this possibility is the finding that BuChE, components (Brandan and Inestrosa, 1993) , and proteoan enzyme that lacks most of the amino acids of the glycans (Snow et al., 1988) . Recent studies indicate that peripheral anionic site (Harel et al., 1992; Vellom et al., perlecan, a heparan sulfate proteoglycan, infused to-1993; Radic et al., 1993) , was not able to stimulate the gether with A␤1-40 into rat brain, induces the formation formation of amyloid fibrils. Our results, which show that of amyloid deposits adjacent to the infusion site (Snow the ability of AChE to promote amyloid formation was et al., 1994). Therefore, it is possible that AChE and a inhibited by propidium and decamethonium, point to heparan sulfate proteoglycan might play a role in prothe involvement of the peripheral anionic binding site moting the assembly of Alzheimer A␤ peptide into filain the interaction of the enzyme with the A␤ peptide; however, the result with BW284c51 is not consistent ments. In this context, it is interesting to mention that
Experimental Procedures
asymmetric AChE, an enzyme form that increases severalfold in AD brain (Younkin et al., 1986) and is apparently 
Deposition in AD?
not otherwise specified, were obtained from commercial sources.
The cholinergic system is affected in AD (Perry et al., 1978; Whitehouse et al., 1981; Coyle et al., 1983 ; Geula
Substrates and Inhibitors
and , and despite a decrease in the level ( Struble et al., 1982) . In mature plaques, AChE is predominantly associated with the amyloid, rather than with
Purification of Bovine Brain AChE
The tetrameric G 4 AChE form (sedimentation coefficient 10.7 S) was the neuritic component (Carson et al., 1991) . Within this purified from bovine caudate nucleus, using acridine-affinity chrocontext, the fact that AChE behaves as an amyloidmatography (Inestrosa et al., 1987) . Both specific activities (6,000
promoting factor suggests that the enzyme may play U/mg protein), and staining intensities following polyacrylamide gel a role in amyloid deposition. Regarding the neuronal electrophoresis (a single band of 68 kDa) were used to verify purity.
damage and the deposition of amyloid fibrils that exhibit a restricted localization in Alzheimer's brain (Terry et al.,
Recombinant AChEs
Recombinant human AChE was purchased from Sigma, and con-1994), it is unclear how the low (nanomolar) levels of sists of 90% of dimers (G2, 6.5 S) and 10% of tetramers (G4, 10.7 S) soluble A␤ present in the brain (Selkoe, 1994) give rise of catalytic subunits (Velan et al., 1991) , and a G1 (4.8 S) mouse to aggregated A␤ in the form of stable amyloid plaques.
recombinant. mAChE was a gift of Dr. Palmer Taylor, University of Therefore, the availability of the A␤ peptide itself is not California, San Diego, La Jolla, CA.
a rate-limiting step in its deposition (Selkoe, 1994) and other local promoting factors like AChE may play an Aggregation Studies of A␤ Peptides: Turbidity Lyophilized aliquots of the peptides were resuspended in 0.1M soactive role in the formation of mature toxic plaques (Iverdium acetate, (pH 5.0). At various times, the aggregation was desen et al., 1995). Loss of cellular AChE and deposition of tected via turbidity measurements at 400 nm, as described prethe secreted enzyme within preamyloid diffuse plaques viously (Jarret et al., 1993; Soto et al., 1995) . Specifically, A␤1-40 and senile plaques (Struble et al., 1982; synthetic peptide (240 M) was incubated alone or in the presence 1993), may be due to the degeneration of AChE-conof affinity purified AChE (2.4 M) at a molar ratio A␤:AChE of 100:1. The incubation was carried out at room temperature in phosphatetaining neurons (Geula and Mesulam, 1994) such as the lightly stained neurons located in the entorhinal cortex, the CA1/subiculum of the hippocampus, Amyloid Detection in Suspension: Thioflavine-T and the amygdala, are the first to be affected in the
Based Fluorometric Assay
Aliquots of peptides at the indicated concentrations were incubated pathological process of AD (Shen, 1994) . Consistent for different times at room temperature in 0.1M Tris-HCl, (pH 7.4).
with the possibility that AChE would play a relevant role
For coincubation experiments, aliquots of AChE to a final molar ratio in AD is a recent work of Soreq and coworkers (Beeri of 100:1 were added. To quantitate amyloid formation we used a et al., 1995) , showing that transgenic expression of Huthioflavine-T fluorescence method as described (LeVine, 1993; AChE induces progressive cognitive deterioration in et al., 1995) . Thioflavine-T binds specifically to amyloid and this binding produces a shift in its emission spectrum and a fluorescent mice. Therefore, it is intriguing to speculate that AChE (around 300 s) were averaged after subtracting the background Amitai, G., and Taylor, P. (1991) Bourne, Y., Taylor, P., Marchot, P. (1995) . Acetylcholinesterase inhiSedimentation Velocity Analysis bition by fasciculin: crystal structure of the complex. Cell 83, 1-10. Affinity-purified brain AChE, as well as recombinant HuAChE and Brandan, E., and Inestrosa, N.C. (1993) . Extracellular matrix compomAChE were submitted to sedimentation velocity analysis as denents and amyloid in neuritic plaques of the Alzheimer's disease. scribed previously (Inestrosa et al., 1983 .
Gen. Pharmacol. 24, 1063-1068.
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